183 related articles for article (PubMed ID: 10837485)
1. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
Mullin JL; Gorkun OV; Binnie CG; Lord ST
J Biol Chem; 2000 Aug; 275(33):25239-46. PubMed ID: 10837485
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
[TBL] [Abstract][Full Text] [Related]
3. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.
Higgins DL; Lewis SD; Shafer JA
J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903
[TBL] [Abstract][Full Text] [Related]
4. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
5. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
6. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
Okumura N; Terasawa F; Haneishi A; Fujihara N; Hirota-Kawadobora M; Yamauchi K; Ota H; Lord ST
J Thromb Haemost; 2007 Dec; 5(12):2352-9. PubMed ID: 17922804
[TBL] [Abstract][Full Text] [Related]
7. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
[TBL] [Abstract][Full Text] [Related]
8. Analysis of A alpha 251 fibrinogen: the alpha C domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X.
Gorkun OV; Henschen-Edman AH; Ping LF; Lord ST
Biochemistry; 1998 Nov; 37(44):15434-41. PubMed ID: 9799505
[TBL] [Abstract][Full Text] [Related]
9. Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.
Weitz JI; Leslie B
J Clin Invest; 1990 Jul; 86(1):203-12. PubMed ID: 2365816
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.
Profumo A; Turci M; Damonte G; Ferri F; Magatti D; Cardinali B; Cuniberti C; Rocco M
Biochemistry; 2003 Oct; 42(42):12335-48. PubMed ID: 14567695
[TBL] [Abstract][Full Text] [Related]
11. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution.
Southan C; Lane DA; Bode W; Henschen A
Eur J Biochem; 1985 Mar; 147(3):593-600. PubMed ID: 3979390
[TBL] [Abstract][Full Text] [Related]
13. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
Okumura N; Haneishi A; Terasawa F
Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
[TBL] [Abstract][Full Text] [Related]
14. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
Ebert RF; Schreiler WE; Bell WR
Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
Bilezikian SB; Nossel HL; Butler VP; Canfield RE
J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
Hirota-Kawadobora M; Kani S; Terasawa F; Fujihara N; Yamauchi K; Tozuka M; Okumura N
J Thromb Haemost; 2005 May; 3(5):983-90. PubMed ID: 15869595
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.
Pechik I; Yakovlev S; Mosesson MW; Gilliland GL; Medved L
Biochemistry; 2006 Mar; 45(11):3588-97. PubMed ID: 16533041
[TBL] [Abstract][Full Text] [Related]
20. Fibrinopeptides A and B release in the process of surface fibrin formation.
Riedel T; Suttnar J; Brynda E; Houska M; Medved L; Dyr JE
Blood; 2011 Feb; 117(5):1700-6. PubMed ID: 21106983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
